Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pancreatic Ductal Adenocarcinoma - Microbiome as Predictor of Subtypes

NCT04922515 is registered in ClinicalTrials.gov with University Medical Center Goettingen as lead sponsor.

NCT NCT04922515
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04922515 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pancreatic Ductal Adenocarcinoma - Microbiome as Predictor of Subtypes
Lead sponsor
University Medical Center Goettingen
Phase
Not applicable
Overall status
Unknown status
Start date
April 25, 2020
Completion date
December 31, 2023
Enrollment
200 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer